Ex-vivo treatment of immunological disorders with PKC-theta inhibitors

Details for Australian Patent Application No. 2010241701 (hide)

Owner New York University Boehringer Ingelheim International GmbH

Inventors Brown, Maryanne; Dustin, Michael; Zanin-Zhorov, Alexandra

Agent Spruson & Ferguson

Pub. Number AU-A-2010241701

PCT Pub. Number WO2010/126967

Priority 61/173,237 28.04.09 US

Filing date 28 April 2010

Wipo publication date 4 November 2010

International Classifications

A61K 31/505 (2006.01) - Pyrimidines

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

Event Publications

13 October 2011 PCT application entered the National Phase

  PCT publication WO2010/126967 Priority application(s): WO2010/126967

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010241706-ERG monoclonal antibodies

2010241659-Pesticide compositions and applicators